PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Guofang Chen

Department of Neurology, Xuzhou Central Hospital, Xuzhou, 221009, China. Electronic address: cgfxdd@126.com.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 7, 2026 · JOURNAL ARTICLE

Heterostructure nanozyme-synergistically modulated electrochemiluminescence/photoelectrochemical sensing platform for detection of Alzheimer's disease biomarkers in plasma samples.

Biosensors & Bioelectronics

This is a proof-of-concept study of a novel analytical platform in plasma samples; it demonstrates technical feasibility of a biomarker detection method but provides no clinical validation, patient outcomes, or comparison to existing diagnostic standards.

Hypothesis-GeneratingWeiwei Liu Biomarkers Qiumei Feng

Study details

InterventionPtPd/CeO2 heterostructure nanozyme-modulate…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support